BIOCON
|
The Current P/B Ratio of BIOCON is 1.98.
Share Price | ₹289.6 | Apr 24,2024 |
Market Cap | ₹34,763.4 Cr | |
Book Value | ₹17,592.9 Cr | Mar2023 - Consolidated Results |
Price/Book | 1.98x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹34,763.4 Cr] as on Apr 24,2024
(/) Book Value [ ₹17,592.9 Cr] based on Mar2023 - Consolidated Results
(=) P/B Ratio [ 1.98x ]
Thus, for BIOCON , the investors are currently willing to pay '1.98 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 4.77x.
- BIOCON 's operated at median p/b ratio of 4.92x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2021 at 6.57x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
BIOCON | 17,592.90 | 1.98 | 34,763.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.37 | 356,625.0 |
CIPLA LTD | 23,346.00 | 4.84 | 112,938.0 |
DR REDDYS LABORATORIES LTD | 23,140.40 | 4.29 | 99,276.9 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.36 | 93,921.9 |
DIVIS LABORATORIES LTD | 12,767.10 | 7.94 | 101,315.0 |
MANKIND PHARMA LTD | 7,435.16 | 12.93 | 96,143.2 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 14.66 | 90,872.6 |
LUPIN LTD | 12,315.60 | 5.85 | 72,010.8 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.37 | 63,492.3 |
ABBOTT INDIA LTD | 3,146.02 | 17.20 | 54,105.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 1.98x |
Max industry PB | 17.20x |
Median industry PB | 5.85x |
Average industry PB | 7.62x |
You may also like the below Video Courses